183 related articles for article (PubMed ID: 37595204)
1. Impact of Latent M. tuberculosis Infection Treatment on Time to CD4/CD8 Recovery in Acute, Recent, and Chronic HIV Infection.
Grinsztejn E; Cardoso SW; Velasque L; Hoagland B; Dos Santos DG; Coutinho C; Cruz Silva SDC; Nazer SC; Ferreira ACG; Castilho J; Grinsztejn B; Veloso VG
J Acquir Immune Defic Syndr; 2023 Dec; 94(4):355-363. PubMed ID: 37595204
[TBL] [Abstract][Full Text] [Related]
2. Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation.
Davy-Mendez T; Napravnik S; Zakharova O; Kuruc J; Gay C; Hicks CB; Mcgee KS; Eron JJ
J Acquir Immune Defic Syndr; 2018 Dec; 79(4):510-518. PubMed ID: 30142143
[TBL] [Abstract][Full Text] [Related]
3. Determinants of suboptimal CD4
Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
[TBL] [Abstract][Full Text] [Related]
4. Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelines.
Zhabokritsky A; Szadkowski L; Cooper C; Loutfy M; Wong A; McClean A; Hogg RS; Walmsley SL;
J Antimicrob Chemother; 2021 Feb; 76(3):729-737. PubMed ID: 33249444
[TBL] [Abstract][Full Text] [Related]
5. Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART.
Holroyd KB; Han WM; Apornpong T; Trautmann L; Gatechompol S; Hiransuthikul A; Ubolyam S; Sacdalan C; Sriplienchan S; Kanaprach R; Kerr S; Avihingsanon A; Spudich S; Chan P
HIV Med; 2024 Jun; 25(6):725-736. PubMed ID: 38383057
[TBL] [Abstract][Full Text] [Related]
6. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
[TBL] [Abstract][Full Text] [Related]
7. Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV-1 infection: results from a longitudinal study in the French ANRS Primo cohort.
Novelli S; Delobel P; Bouchaud O; Avettand-Fenoel V; Fialaire P; Cabié A; Souala F; Raffi F; Catalan P; Weiss L; Meyer L; Goujard C
J Int AIDS Soc; 2020 Apr; 23(4):e25485. PubMed ID: 32333726
[TBL] [Abstract][Full Text] [Related]
8. Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.
Stockdale AJ; Nkuranga J; Török ME; Faragher B; Lalloo DG
Trop Med Int Health; 2013 Jul; 18(7):907-14. PubMed ID: 23590229
[TBL] [Abstract][Full Text] [Related]
9. Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.
Siika AM; Yiannoutsos CT; Wools-Kaloustian KK; Musick BS; Mwangi AW; Diero LO; Kimaiyo SN; Tierney WM; Carter JE
PLoS One; 2013; 8(1):e53022. PubMed ID: 23301015
[TBL] [Abstract][Full Text] [Related]
10. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection.
Wong EB; Akilimali NA; Govender P; Sullivan ZA; Cosgrove C; Pillay M; Lewinsohn DM; Bishai WR; Walker BD; Ndung'u T; Klenerman P; Kasprowicz VO
PLoS One; 2013; 8(12):e83474. PubMed ID: 24391773
[TBL] [Abstract][Full Text] [Related]
11. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection.
Thornhill J; Inshaw J; Kaleebu P; Cooper D; Ramjee G; Schechter M; Tambussi G; Fox J; Samuel M; Miro JM; Weber J; Porter K; Fidler S
J Acquir Immune Defic Syndr; 2016 Sep; 73(1):69-73. PubMed ID: 27070122
[TBL] [Abstract][Full Text] [Related]
13. Impact of antiretroviral and tuberculosis therapies on CD4
Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
[TBL] [Abstract][Full Text] [Related]
15. CD4
Vivancos-Gallego MJ; Okhai H; Perez-Elías MJ; Gomez-Ayerbe C; Moreno-Zamora A; Casado JL; Quereda C; Sanz JM; Sanchez-Conde M; Serrano-Villar S; Del Campo S; Dronda F; Galan JC; Sabin CA; Moreno S
Antivir Ther; 2020; 25(2):91-100. PubMed ID: 32338638
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
[TBL] [Abstract][Full Text] [Related]
17. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.
Miranda A; Morgan M; Jamal L; Laserson K; Barreira D; Silva G; Santos J; Wells C; Paine P; Garrett D
PLoS One; 2007 Sep; 2(9):e826. PubMed ID: 17786198
[TBL] [Abstract][Full Text] [Related]
18. T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia.
Wondmagegn T; Damtie D; Genetu M; Biadgo B; Lemma M; Negash M
BMC Infect Dis; 2020 Feb; 20(1):109. PubMed ID: 32033581
[TBL] [Abstract][Full Text] [Related]
19. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.
Assefa A; Gelaw B; Getnet G; Yitayew G
BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855
[TBL] [Abstract][Full Text] [Related]
20. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
